Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Repare The...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: March 26, 2023

30+ Health Leaders Explore Strategies to Ease Hospital-to-Home Patient Transitions • Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC, a partner of Veterans for Trump • GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Office • SOTERA HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Los • Philadelphia Works Names First Female Chief Operating Officer • ARGO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Argo B • Build community with shared future, create better world • National University Receives 2023 Military Friendly® Gold Designation • SOTERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sote • Atlanta Housing, Residents Celebrate 102nd Birthday of Clara "Mama" Bridges • AI-Powered Stylitics Launches Latest Platform with First-of-Its-Kind Automated Styling Technology for Retailers • SAMARITAN'S PURSE RUSHING HELP TO FAMILIES IMPACTED BY DEADLY TORNADOES IN MISSISSIPPI • Statement from the Chief Public Health Officer of Canada on World TB Day • DISH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DISH Network Corporatio • Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference • SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Stanley Black & Decker, Inc. with Losses of $100,000 t • Early Education Leadership Conference in Hershey Brings Together Hundreds of Child Advocates • HYZON MOTORS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers • ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting • Here Comes Bunnysaurus Rex Hopping Down the Dinosaur Trail

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Repare Therapeutics Inc. (RPTX) Investigation

NEW YORK , February 08 /Businesswire/ - Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Repare Therapeutics Inc. (“Repare” or the “Company”) (NASDAQ: RPTX). Investors who purchased Repare securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/rptx.

The investigation concerns whether Repare has violated federal securities laws.

On or around June 18, 2020, Repare conducted its initial public offering (“IPO”), issuing 11 million shares of common stock priced at $20.00 per share. Then, on February 3, 2023, Morgan Stanley analyst Jeffrey Hung downgraded Repare to Equal Weight from Overweight. Hung cited concerns over an upcoming Phase 1 readout for the Company’s PKMYT1 inhibitor RP-6306, noting that “PKMYT1 is a novel target” and opining that initial Phase 1 data for RP-6306 will focus on Pharmacokinetics, Pharmacodynamics, and proving target inhibition. On this news, Repare’s stock price fell $0.78 per share, or 5.94%, to close at $12.36 per share on February 3, 2023.

If you are aware of any facts relating to this investigation or purchased Repare shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/rptx. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.